https://www.redlam.org/2026-10-02 https://www.redlam.org/acciones/desafio-internacional-a-gilead/2017-09-26 https://www.redlam.org/acciones/dia-mundial-de-la-hepatitis/2017-09-26 https://www.redlam.org/acciones/drop-the-case/2016-03-11 https://www.redlam.org/acciones/foro-acceso-a-medicamentos-y-propiedad-intelectual/presentaciones/2015-09-16 https://www.redlam.org/acciones/foro-acceso-a-medicamentos-y-propiedad-intelectual/2017-09-26 https://www.redlam.org/acciones/foro-politicas-de-produccion-local-de-medicamentos/presentaciones/2015-09-16 https://www.redlam.org/acciones/foro-politicas-de-produccion-local-de-medicamentos/2017-09-26 https://www.redlam.org/acciones/gtpi-reclama-en-brasil-por-la-defensa-de-la-salud/2017-09-26 https://www.redlam.org/acciones/la-sociedad-civil-hace-frente-a-las-patentes-farmaceuticas/2014-01-16 https://www.redlam.org/acciones/licencia-obligatoria-para-imatinib-colombia/2017-09-26 https://www.redlam.org/acciones/nuestra-salud-no-se-negocia-peru-2013/2014-01-16 https://www.redlam.org/acciones/oposicion-a-la-patente-de-atripla/2015-09-16 https://www.redlam.org/acciones/2015-02-06 https://www.redlam.org/biblioteca/analisis-resolucion-cd58-6-ops/2020-09-23 https://www.redlam.org/biblioteca/boletines/boletin-1/2020-08-19 https://www.redlam.org/biblioteca/boletines/boletin-10/2020-08-19 https://www.redlam.org/biblioteca/boletines/boletin-11/2020-08-19 https://www.redlam.org/biblioteca/boletines/boletin-12/2020-08-19 https://www.redlam.org/biblioteca/boletines/boletin-13/2020-08-19 https://www.redlam.org/biblioteca/boletines/boletin-2/2020-08-19 https://www.redlam.org/biblioteca/boletines/boletin-3/2020-08-19 https://www.redlam.org/biblioteca/boletines/boletin-4/2020-08-19 https://www.redlam.org/biblioteca/boletines/boletin-5/2020-08-19 https://www.redlam.org/biblioteca/boletines/boletin-6/2020-08-19 https://www.redlam.org/biblioteca/boletines/boletin-7/2020-08-19 https://www.redlam.org/biblioteca/boletines/boletin-8/2020-08-19 https://www.redlam.org/biblioteca/boletines/boletin-9/2020-08-19 https://www.redlam.org/biblioteca/boletines/2020-05-29 https://www.redlam.org/biblioteca/2015-06-24 https://www.redlam.org/contacto/ https://www.redlam.org/en/contact/ https://www.redlam.org/en/news/ https://www.redlam.org/en/who-we-are/ https://www.redlam.org/en/ https://www.redlam.org/formacion/curso-virtual-2013/convocatoria/2015-09-16 https://www.redlam.org/formacion/curso-virtual-2013/2015-07-13 https://www.redlam.org/formacion/curso-virtual-2014/convocatoria/2015-09-16 https://www.redlam.org/formacion/curso-virtual-2014/2015-07-13 https://www.redlam.org/formacion/curso-virtual-2015/convocatoria/2015-10-20 https://www.redlam.org/formacion/curso-virtual-2015/2017-10-04 https://www.redlam.org/formacion/curso-virtual-2017/inscripcion/2017-10-04 https://www.redlam.org/formacion/curso-virtual-2017/2017-10-04 https://www.redlam.org/formacion/2015-09-16 https://www.redlam.org/institucional/objetivos/2015-09-16 https://www.redlam.org/institucional/oportunidades/abogado-especializado-en-propiedad-intelectual-e-investigacion/2016-06-05 https://www.redlam.org/institucional/oportunidades/asistente-tecnico-en-coordinacion-de-proyectos/2016-06-05 https://www.redlam.org/institucional/oportunidades/asistente-tecnico/2015-02-10 https://www.redlam.org/institucional/oportunidades/consultor-quimicofarmaceutico/2016-06-05 https://www.redlam.org/institucional/oportunidades/consultora-en-comunicacion/2016-06-05 https://www.redlam.org/institucional/oportunidades/consultora-en-incidencia-politica/2016-06-05 https://www.redlam.org/institucional/oportunidades/oportunidad-trabajos-ofrecidos-fgep-argentina/2019-05-20 https://www.redlam.org/institucional/oportunidades/oportunidad-trabajos-ofrecidos-por-fundacion-gep-argentina/2019-05-20 https://www.redlam.org/institucional/oportunidades/traductora-de-ingles-tecnico-cientifico/2016-06-05 https://www.redlam.org/institucional/oportunidades/2017-09-19 https://www.redlam.org/institucional/2025-10-29 https://www.redlam.org/mapa-regional/ https://www.redlam.org/noticias/2020-05-10 https://www.redlam.org/pt/contato/ https://www.redlam.org/pt/quem-somos/ https://www.redlam.org/pt/ https://www.redlam.org/noticias/lenacapavir-y-las-venas-abiertas-de-america-latina/2026-10-02 https://www.redlam.org/noticias/licencia-obligatoria-de-dolutegravir-en-colombia/2025-02-17 https://www.redlam.org/noticias/estudio-comparativo-de-precios/2024-12-17 https://www.redlam.org/noticias/llamado-a-defender-la-licencia-obligatoria-de-dolutegravir-en-colombia/2024-07-22 https://www.redlam.org/noticias/licencia-obligatoria-en-colombia-sobre-dolutegravir/2024-04-26 https://www.redlam.org/noticias/declaracion-redlam/2023-10-19 https://www.redlam.org/noticias/declaracion-de-estambul-una-hoja-de-ruta-para-proteger-el-derecho-a-la-vida-en-un-orden-multilateral-que-falla/2023-09-22 https://www.redlam.org/noticias/informe-de-la-serie-debates-urgentes/2023-08-09 https://www.redlam.org/noticias/dialogos-politicos-acceso-a-tratamientos-y-vacunas-en-el-marco-de-la-pandemia-de-covid19/2020-09-24 https://www.redlam.org/noticias/fundacion-gep-entre-lxs-espiadxs-por-la-afi/2020-08-04 https://www.redlam.org/en/news/argentina-fundacion-gep-opposed-gileads-patent-application-on-remdesivir/2020-08-04 https://www.redlam.org/noticias/el-ministro-de-economia-de-bolsonaro-paulo-guedes-quiere-privatizar-el-instituto-nacional-de-propiedad-intelectual-y-correr-al-analisis-de-patentes-de-la-esfera-de-la-administracion-del-estado/2020-02-14 https://www.redlam.org/noticias/la-pesada-herencia-del-ajuste-en-los-proximos-meses-tambien-va-a-haber-faltantes-de-medicamentos/2020-06-08 https://www.redlam.org/noticias/redlam-en-ginebra-una-semana-de-acciones-contra-el-poder-corporativo-y-por-la-soberania-de-los-pueblos/2019-12-23 https://www.redlam.org/en/news/redlam-in-geneva/2019-10-16 https://www.redlam.org/noticias/cronica-redlam-en-aids-2018/2019-10-04 https://www.redlam.org/noticias/argentina-comunicado-faltantes-de-medicamentos-para-vih-acceso-a-la-informacion-publica-y-derecho-a-la-salud/2020-01-14 https://www.redlam.org/noticias/argentina-mas-de-15-mil-personas-con-vih-sin-medicacion-la-informacion-oficial-confirma-que-faltan-y-van-a-faltar-mas-medicamentos/2020-01-14 https://www.redlam.org/noticias/lanzamiento-de-la-plataforma-america-latina-mejor-sin-tlc/2019-10-01 https://www.redlam.org/noticias/el-reclamo-por-el-ajuste-en-salud-en-argentina-llego-a-la-sede-del-fmi/2019-10-01 https://www.redlam.org/noticias/cumbre-de-los-pueblos-revivi-el-foro-soberania-sanitaria-el-impacto-del-neoliberalismo-sobre-el-derecho-a-la-salud/2019-10-04 https://www.redlam.org/noticias/foro-soberania-sanitaria-el-impacto-del-neoliberalismo-sobre-el-derecho-a-la-salud/2019-10-01 https://www.redlam.org/noticias/fundacion-gep-y-redlam-aportan-recomendaciones-en-la-conferencia-mundial-sobre-acceso-productos-medicos/2019-05-20 https://www.redlam.org/noticias/redlam-denuncia-violaciones-al-derecho-a-la-salud-ante-el-consejo-de-derechos-humanos-de-la-onu/2019-05-20 https://www.redlam.org/noticias/organizaciones-de-la-sociedad-civil-demandan-ante-naciones-unidas-que-los-pacientes-reciban-mas-proteccion-que-las-patentes/2019-05-20 https://www.redlam.org/noticias/redlam-compartio-estrategias-experiencias-trabajo-defensa-derecho-salud-foro-acceso-medicamentos-propiedad-intelectual-bioetica-bogota/2019-05-20 https://www.redlam.org/noticias/gtpirebrip-divulgo-carta-abierta-ministro-desarrollo-industria-comercio-exterior-brasil-marcos-pereira/2019-05-20 https://www.redlam.org/noticias/sociedad-civil-peruana-exige-presidente-kuczynski-soluciones-acceso-medicamentos-interes-publico-atazanavir-licencia-obligatoria/2019-05-20 https://www.redlam.org/noticias/sociedad-civil-argentina-hace-historia-proyecto-nueva-ley-vihsida-dictamen-comision-salud-diputados/2019-05-20 https://www.redlam.org/noticias/victoria-de-la-salud-el-inpi-argentino-rechaza-patentes-sobre-medicamento-para-el-vihsida/2019-05-20 https://www.redlam.org/noticias/comision-de-salud-congreso-peru-declara-interes-publico-medicamento-atazanavir/2019-05-20 https://www.redlam.org/noticias/historico-aporte-sociedad-civil-argentina-desestiman-patente-medicamento-vihsida/2019-05-20 https://www.redlam.org/noticias/brasil-gobierno-temer-enterro-principal-medida-proteccion-acceso-medicamentos/2019-05-20 https://www.redlam.org/noticias/alerta-tratado-libre-comercio-mercosur-union-europea-jaque-salud-latinoamerica/2019-05-20 https://www.redlam.org/noticias/inscripcion-curso-virtual-redlam-acceso-a-medicamentos-propiedad-intelectual/2019-05-20 https://www.redlam.org/noticias/colombia-ministro-de-salud-anuncia-declaracion-interes-publico-imatinib-en-firme/2019-05-20 https://www.redlam.org/noticias/demandas-judiciales-multinacionales-farmaceuticas-amenazan-salvaguardas-de-salud-publica-reporte-naciones-unidas/2019-05-20 https://www.redlam.org/noticias/boletin-especial-redlam-cobertura-conferencia-internacional-de-vihsida-2016/2020-05-29 https://www.redlam.org/noticias/comunicado-de-prensa-anuncio-de-declaracion-de-interes-publico-de-imatinib-en-colombia/2019-05-20 https://www.redlam.org/noticias/argentina-suma-nueva-meta-para-la-agenda-del-vihsida-en-naciones-unidas-impulsando-propuestas-de-fundacion-gep/2019-05-20 https://www.redlam.org/noticias/naciones-unidas-fgep-y-redlam-alzaron-la-voz-en-audiencia-de-sociedad-civil-para-defender-el-acceso-universal-a-medicamentos-en-proxima-declaracion-politica/2019-05-20 https://www.redlam.org/noticias/contribucion-de-la-redlam-al-panel-de-alto-nivel-de-la-onu-sobre-acceso-a-medicamentos/2019-05-20 https://www.redlam.org/noticias/gtpirebrip-organizo-charlas-debate-con-paul-benkimoun-periodista-de-salud-de-le-monde-en-san-pablo-brasilia-y-rio-de-janeiro/2019-05-20 https://www.redlam.org/en/news/aids-film-festival-expands-debate-on-access-to-medicines-and-strengthens-role-of-civil-society/2015-12-15 https://www.redlam.org/en/news/fgep-discussed-access-to-medicines-at-the-encuentro-nacional-de-equipos-de-salud/2015-12-15 https://www.redlam.org/en/news/brazils-patent-law-reform-public-hearing-at-the-house-of-representatives/2015-12-15 https://www.redlam.org/en/news/redlam-newsletter/2015-12-15 https://www.redlam.org/noticias/la-coordinadora-general-de-la-redlam-ha-sido-convocada-para-integrar-el-grupo-asesor-de-expertos-del-secretario-general-de-naciones-unidas-ban-ki-moon-en-materia-de-innovacion-desarrollo-y-acceso-a/2019-05-20 https://www.redlam.org/noticias/pronunciamiento-redlam-1-de-diciembre-2015/2019-05-20 https://www.redlam.org/noticias/anmat-aprobo-el-registro-sanitario-de-sofosbuvir-y-un-laboratorio-nacional-anuncio-que-lanzara-al-mercado-su-version-generica/2019-05-20 https://www.redlam.org/en/news/ifarma-leads-colombias-civil-society-movements-for-a-compulsory-license-to-be-approved-for-imatinib-through-different-actions/2015-12-15 https://www.redlam.org/noticias/reforma-de-la-ley-de-patentes-audiencia-publica-en-brasil/2015-11-16 https://www.redlam.org/en/news/the-4th-90-affordability-of-medicines-unaids-90-90-90-strategy/2019-05-20 https://www.redlam.org/noticias/propuesta-argentina-para-defender-la-soberania-sanitaria-es-valorada-como-ejemplo-para-el-mundo-por-la-organizacion-de-naciones-unidas/2019-05-20 https://www.redlam.org/noticias/documento-consenso-argentino-90-90-90-y-90/2019-05-20 https://www.redlam.org/noticias/festival-de-cine-sobre-sida-debate-sobre-acceso-a-medicamentos/2015-11-16 https://www.redlam.org/noticias/argentina-suma-a-la-estrategia-90-90-90-contra-el-vihsida-una-cuarta-meta-clave-90-de-los-tratamientos-a-precios-asequibles/2019-05-20 https://www.redlam.org/noticias/argentina-compra-version-generica-de-importante-droga-para-garantizar-sustentabilidad-en-el-tratamiento-de-personas-con-vih/2019-05-20 https://www.redlam.org/noticias/personas-con-hepatitis-c-denunciaron-precios-extorsivos-de-la-industria-farmaceutica-en-simposio-internacional/2019-05-20 https://www.redlam.org/en/news/world-hepatitis-day-while-activists-are-calling-for-access-to-treatment-companies-announced-record-profits/2015-12-15 https://www.redlam.org/noticias/dia-mundial-contra-la-hepatitis-viral-desafios-y-avances-en-argentina-por-el-acceso-a-tratamientos-que-curan/2019-05-20 https://www.redlam.org/en/news/world-viral-hepatitis-day-challenges-and-progress-in-argentina-for-access-to-treatments-that-cure/2015-12-15 https://www.redlam.org/en/news/fundacion-grupo-efecto-positivo-and-the-ministry-of-industry-agree-on-agenda-to-jointly-work-for-access-to-medicines/2015-11-04 https://www.redlam.org/noticias/fgep-y-ministerio-industria-definen-agenda/2019-05-20 https://www.redlam.org/noticias/licencia-obligatoria-atazanavir-peru/2019-05-20 https://www.redlam.org/en/news/in-spite-of-a-35-price-reduction-a-compulsory-license-must-be-applied-for-atazanavir-in-peru/2015-11-04 https://www.redlam.org/en/news/gtpi-intellectual-property-working-group-asked-the-brazilian-minister-of-health-for-a-stronger-stance-to-preserve-health-defense-mechanisms/2015-12-15 https://www.redlam.org/noticias/hepatitis-c-y-vih-foro-internacional-10-junio-lima-peru/2019-05-20 https://www.redlam.org/noticias/hepatitis-c-oposicion-a-la-patente-de-sofosbuvir-en-argentina/2019-05-20 https://www.redlam.org/en/news/actions-of-civil-society-challenge-patents-of-multinational-gilead-to-prevent-misappropriation-of-drugs-against-hepatitis-c-and-guarantee-access-to-treatment-worldwide/2015-12-15 https://www.redlam.org/en/news/patent-opposition-for-sofosbuvir-requested-in-argentina/2015-12-15 https://www.redlam.org/noticias/piden-rechazo-de-patente-de-sofosbuvir/2019-05-20 https://www.redlam.org/noticias/argentina-paga-us-2304-por-ano-por-truvada-cuando-podria-comprarlo-a-us-74/2019-05-20 https://www.redlam.org/noticias/argentina-dia-internacional-lucha-contra-el-sida-comunicado-redar-positiva-fgep/2019-05-20 https://www.redlam.org/noticias/entrevista-coordinadora-redlam-corresponsales-clave/2019-05-20 https://www.redlam.org/noticias/pronunciamiento-licencia-voluntaria-sobre-sofosbuvir-y-ledipasvir-hepatitis-c/2019-05-20 https://www.redlam.org/noticias/acciones-en-argentina-colombia-y-peru-nota-de-corresponsales-clave/2019-05-20 https://www.redlam.org/noticias/pronunciamiento-redlam-1ro-diciembre-2013/2019-05-20 https://www.redlam.org/noticias/oposicion-a-la-patente-de-atripla-en-argentina/2019-05-20 https://www.redlam.org/noticias/kaletra-acciones-en-colombia/2019-05-20 https://www.redlam.org/noticias/casi-un-centenar-de-inscripciones-al-curso-virtual-de-redlam-informacion-relevante/2019-05-20 https://www.redlam.org/noticias/mas-de-130-organizaciones-demandan-reforma-de-la-ley-de-patentes-de-sudafrica/2019-05-20 https://www.redlam.org/noticias/la-redlam-convoca-a-activistas-a-participar-del-curso-virtual-sobre-acceso-a-medicamentos-y-propiedad-intelectual/2019-05-20 https://www.redlam.org/temas/ https://www.redlam.org/temas/acceso-a-medicamentos/2026-10-02 https://www.redlam.org/temas/incidencia-internacional/2023-10-19 https://www.redlam.org/temas/vih/2019-12-23 https://www.redlam.org/temas/accion-directa/2020-09-24 https://www.redlam.org/temas/patentes/2017-07-26 https://www.redlam.org/temas/hepatitis-c/2015-11-11 https://www.redlam.org/temas/comercio-y-salud/2018-11-27 https://www.redlam.org/mapa-regional/mexico/ https://www.redlam.org/mapa-regional/colombia/ https://www.redlam.org/mapa-regional/peru/ https://www.redlam.org/mapa-regional/brasil/ https://www.redlam.org/mapa-regional/argentina/ https://www.redlam.org/en/regional-map/ https://www.redlam.org/en/regional-map/mexico/ https://www.redlam.org/en/regional-map/colombia/ https://www.redlam.org/en/regional-map/peru/ https://www.redlam.org/en/regional-map/brazil/ https://www.redlam.org/en/regional-map/argentina/ https://www.redlam.org/pt/mapa-regional/ https://www.redlam.org/pt/mapa-regional/mexico/ https://www.redlam.org/pt/mapa-regional/colombia/ https://www.redlam.org/pt/mapa-regional/peru/ https://www.redlam.org/pt/mapa-regional/brasil/ https://www.redlam.org/pt/mapa-regional/argentina/